Blood Glucose Monitoring Market is estimated to be 19.6 Billion by 2029 with a CAGR of 6.6% during the forecasted period.


Blood glucose monitoring is the process of testing the diabetes level within the blood. It helps to acknowledge the glucose level of blood within the required target range. Blood sugar monitoring devices provide useful insight to manage diabetes. It helps to trace the progress of treatment goal also as observe the effect of medication on blood glucose level and understand how ailment affects the glucose level within the blood. The global blood glucose monitoring market accounted for US$ 11.10 billion in 2020 and is estimated to be US$ 19.6 billion by 2029 and is anticipated to register a CAGR of 6.6.

The report "Global Blood Glucose Monitoring Market, By Type (Self-Monitoring Blood Glucose and Continuous Blood Glucose Monitoring), By Component (Glucometer Devices, Test Strips, Lancets, Sensors, and Receivers), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”.

Key Highlights:

  • In August 2016, Roche launched the Accu-Chek Guide blood glucose monitoring system. The device is designed to make daily glucose monitoring easy.
  • In October 2018, Platinum Equity acquired Lifescan from Johnson & Johnson diabetes care business, with an aim to increase its product offering.
  • In August 2018, Dexcom acquired TypeZero Technologies, which was an extension of long partnership between both companies with an aim to improve its product offering through TypeZero Technologies automated insulin delivery system.

Analyst View:

Rising incidence of diabetes, coupled with increasing geriatric population prone to diabetes is the key factors to drive the market growth. According to the International Diabetes Federation, approximately 424 million people were living with diabetes in 2017 and this number is expected to reach 629 million by 2045. Increasing geriatric population is also propelling the market. According to the World Health Organization (WHO), the global aging population will rise from 12% in 2015 to 22% by 2050. This translates into significant development potential.

The market has significantly benefited from continuous technological advancements and early detection of hypo and hyperglycemic diabetes. Rapidly changing lifestyles, such as smoking and consumption of alcohol and unhealthy foods, are contributing to the rise in the number of diabetes patients worldwide. Obesity is also one of the major factors contributing to diabetes. According to WHO, over 650 million people were obese in 2016 and this number is expected to grow further during the forecast period.

Key Market Insights from the report:        

The global blood glucose monitoring market accounted for 11.0 billion in 2020 and is estimated to be US$ 19.6 billion by 2029 and is anticipated to register a CAGR of 6.6%. The market report has been segmented on the basis of type, component and region.

  • Depending upon type, the self-monitoring blood glucose segment is projected to grow at highest CAGR over the forecast period owing to its ease of use and low cost.
  • Depending upon component, the test strips and lancets segment is projected to grow at highest CAGR over the forecast period.
  • By region, North America has been leading the global market owing to its well-established healthcare sector. Increasing prevalence of obesity and high cost of treatment is also expected to drive the region, along with technological advancements and new product launches.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3947

Competitive Landscape:

The prominent player operating in the global blood glucose monitoring market includes Abbott Laboratories, Arkay, Inc., Bayer Healthcare AG, F. Hoffmann-La Roche Ltd, Goldsite Diagnostics Inc., GlySure Ltd, Sphere Medical Holding plc., Dexcom, Inc., and LifeScan, Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Comments

Post a Comment

Popular posts from this blog

Global Platelet Rich Plasma Market is estimated to be US$ 1003.06 million by 2030 with a CAGR of 11.50% during the forecast period.

Image
Global Platelet Rich Plasma Market accounted for US$ 337.23 million in 2020 and is estimated to be US$ 1003.06 million by 2030 and is anticipated to register a CAGR of 11.50%. Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is created by extracting red blood cells from blood. When the concentration of platelets in human blood is reduced, platelet-rich plasma is separated, which contains a concentration of platelets above typical values. Platelets thicken the blood and aid in the repair of muscles, ligaments, and tendons. They are extremely high in healing and connective tissue development factors. Platelet-rich plasma (PRP) blends the body's natural ability to heal itself with modern technologies. It has a wide range of medical applications, including neurology, orthopaedics, and ophthalmology. It's also employed in procedures like tendon repair and rotator cuff augmentation. The report   " Global Platelet Rich Plasma Market, By Type (Pure Platelet...
Read more

Neurodegenerative Disorder Therapeutics Market - Improvement in the healthcare infrastructure is likely to create new opportunity for the market

Image
Neurodegenerative Disorder Therapeutics Market   accounted for US$ 9.32 billion in 2019 and is estimated to be US$ 21.3 billion by 2029 and is anticipated to register a CAGR of 8.7% The report " Global  Neurodegenerative Disorder Therapeutics Market, By  Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, and Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In November 2019, Alkermes plc and Rodin Therapeutics, Inc. announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin, a privately held biopharmaceutical company focused ...
Read more

Systemic Lupus Erythematosus Market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%

Image
  Systemic Lupus Erythematosus (SLE) is the chronic, autoimmune disorder which involves several organ-systems such as kidney, heart, blood, skin, joints, and lungs in most severe cases, brain. In this disease, the human immune system converts hyperactive and attacks the healthy, normal tissues of the body. SLE can often result in symptoms such as malar rash, sub-acute cutaneous lesions, discoid lesions, arthritis, photosensitivity, oral ulcers, serositis, nephropathy, thrombocytopenia, haemolytic anemia, neurologic involvement, fever, thrombosis, Raynaud’s phenomenon, livedo reticularis, and myositis. The global systemic lupus erythematosus market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%. The report  " Global   Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics), By Route of Administration (Oral, In...
Read more